Yamamoto, Teruyuki <br/><br/>
HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway.  [electronic resource] 

 -  Atherosclerosis  Feb 2003 
 - 213-22 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/s0021-9150(02)00329-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Base Sequence<br/>Cells, Cultured<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Interleukin-1--pharmacology<br/>Intracellular Signaling Peptides and Proteins<br/>Male<br/>Models, Animal<br/>Molecular Sequence Data<br/>Muscle, Smooth, Vascular--cytology<br/>Nitric Oxide Synthase--biosynthesis<br/>Nitric Oxide Synthase Type II<br/>Probability<br/>Protein Serine-Threonine Kinases--metabolism<br/>Pyridines--pharmacology<br/>RNA, Messenger--analysis<br/>Random Allocation<br/>Rats<br/>Rats, Wistar<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sensitivity and Specificity<br/>rho-Associated Kinases